Prognostic impact of residual thoracic disease after neoadjuvant chemotherapy in advanced ovarian cancer patients undergoing interval debulking surgery

International Journal of Gynecological Cancer 2026

View at publisher

Authors: Luca Pace, Lorenzo Novara, Serena Mucciacito, Margherita Giorgi, Daniela Attianese, Giuseppe Vizzielli, Annamaria Ferrero

DOI: 10.1016/j.ijgc.2025.103912

Cited by: 0

Fields of Study & Subjects

Ovarian cancer diagnosis and treatment Intraperitoneal and Appendiceal Malignancies Endometrial and Cervical Cancer Treatments